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Transcriptional regulation in higher eukaryotes frequently involves long-range interactions, up to tens of hundreds of kilobases away, of a
number of cis-acting regulatory DNA elements. Using the chromosome conformation capture technique we have analyzed the expression of a
small 2.5-kb gene, CD68, in different human cell types and show for the first time that short-range interactions may also be critical. In human
monocytes, which produce high levels of CD68 mRNA, the gene is characterized by intramolecular ligations between the promoter and the 3′
intervening region. In cells that poorly express the gene a change in architecture is apparent whereby the promoter preferentially associates with
the terminator region only. Furthermore, alterations in CD68 gene structure are associated with failings in mRNA splicing and changes with the
phosphorylation status of RNA Pol II across the gene. We propose that short-range intrachromosomal interactions may form the basis of
coordinated control of monocyte-specific gene regulation.
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marker molecule for human monocytes and tissue resident
macrophages [1,2]. Its function in these cell types is presently
unknown. It is a 110-kDa heavily glycosylated type I
transmembrane protein with sequence similarity to a family of
ubiquitously expressed lysosomal/plasma membrane shuttling
proteins, typified by lamp-1 [3]. The CD68 protein is intensely
expressed within the endosomal compartment of the cell and
rapidly shuttles to the plasma membrane where it is postulated
to participate in cell adhesion and antigen presentation [4].
Furthermore, previous studies has shown that CD68 may also
bind oxidized low-density lipoproteins and may contribute to
the development of macrophage foam cells in atherosclerotic
plaques [5,6].
As expression of CD68 is primarily restricted to cells of the
mononuclear phagocytic lineage, with considerably lower⁎ Corresponding author. Fax: +44 1865 275515.
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doi:10.1016/j.ygeno.2007.04.010levels associated with CD19+B lymphocytes and CD4+T
lymphocytes, it provides a model for elucidating mechanisms
that control gene expression in different hematopoietic cell
types. Significant progress in identifying components of the
transcription factor machinery that play a role in enhancing or
silencing the CD68 gene in a cell-type-specific manner has been
made. We and others have shown that members of the Ets
transcription factor family and interferon regulatory factor (IRF)
family specifically downregulate the gene in B lymphocytes and
that c-jun is required for maximal expression in moncytic cells
[7–9].
However, it is becoming increasingly more apparent that
the isolation and characterization of DNA binding proteins
associated with proximal promoter regions is not sufficient to
fully elucidate how a gene is regulated. Transcription of a
gene and the regulation of the processes involved occur
within an environment that packages DNA into a highly
organized nucleoprotein structure known as chromatin, which
plays a pivotal role in gene regulation. Recent evidence has
shown that developmental gene regulation requires dynamic
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elements with active genes in expressing cells [10–12].
Furthermore, the transcription of genes into pre-mRNA and
the processing of this message is a highly integrated process
[13–16]. An integral component in the coordination of all
these events is RNA polymerase II (Pol II), in particular its
carboxy-terminal domain (CTD), which is subject to rever-
sible phosphorylation during the transcription cycle [17–22].
High levels of the serine-5-phosphorylated form are asso-
ciated with the beginning of the gene with levels of the
serine-2-phosphorylated form increasing toward the end, and
insufficient phosphorylation of the CTD of RNA Pol II can
result in paused preassembled transcription complexes at the
promoters of nontranscribing genes [23,24]. Recent evidence,
from studies in yeast, has shown that the phosphorylation
status of Pol II across the gene and gene loop formation are
interlinked [25].
In light of these studies we decided to extend our analysis of
CD68 regulation by focusing our attention on both the gene
architecture and the Pol II phosphorylation states across the
gene in the different human cell types. Previously, expression
cassettes have been generated with the 5′ promoter region and
first intron of the human CD68 gene to successfully target
transgenes to myeloid cells [26–28]. This would suggest that
the regulatory elements required to control CD68 expression in
macrophages are localized to the regions spanning the gene
itself and that long-range interaction are less likely to be
important. Using the chromosome conformation capture (3C)
technique [29] we provide evidence that alterations in local gene
architecture are indeed associated with the cell-type-specific
expression of the human CD68 gene. Furthermore, we find that
cells that poorly express CD68 show failings in mRNA splicing
and alterations in the phosphorylation status of Pol II across the
gene. We postulate that short-range interactions may be a
common mechanism to control the transcription of cell-type-
specific genes by promoting efficient transcription elongation
and splicing.
Results
Expression of CD68 mRNA in permissive and nonpermissive
cell lines
We first determined the expression levels of CD68 in
different cell types by reverse transcription (RT)-PCR using
primers that spanned each of the five introns of the human
CD68 gene (Fig. 1A). cDNA was prepared from total RNA
from human monocytic cell lines THP-1 and HL-60, B
lymphocytic cells lines Raji and JY, and a T lymphocytic cell
line Jurkat using oligo(dT) as a primer. As expected, the
highest level of correctly spliced CD68 mRNA expression was
detected in the monocytic cell lines THP-1 and HL-60 (Fig.
1A, lanes 2 and 4). The remaining three cell lines expressed
significantly less mRNA and all of them produced a slower-
migrating product (compare lanes 2 and 4 to lanes 6, 8, and
10). Sequence analysis confirmed that these products corre-
sponded to pre-mRNA as they contained unspliced intronsequences. Genomic DNA contamination was ruled out as
reactions minus the reverse transpsciptase enzyme yielded no
product (Fig. 1A, lanes 1, 3, 5, 7, and 9). To examine the
relative abundance of CD68 mRNA and pre-mRNA in the
different cell types we performed real-time PCR analysis (Figs.
1B and 1C). Using exon-specific primers the B and T
lymphocytic cells showed on average a 100-fold reduction in
CD68 mRNA levels compared to the monocytic cells for both
the exon1/2 and the exon 4/5 regions analyzed (Fig. 1B). All
of the nonmonocytic cells expressed a 4- to 9-fold increase in
pre-mRNA levels (Fig. 1C). The ratio of mRNA to pre-RNA
was significantly greater in the monocytic cells than in the
other cell types (Fig. 1D). On average the monocytic cells
produced 5773-fold more mRNA than pre-mRNA compared
to an average of 11.7-fold for all other cells tested. Similar data
were obtained by real-time PCR analysis of cDNA synthesized
from total RNA using random primers (data not shown).
Immunohistochemical analysis previously indicated that low
levels of CD68 protein are detected in B and T lymphoid cells
and as such it was no surprise that Raji, JY, and Jurkat cells
express low levels of CD68 mRNA [1,2]. However, the fact
that all of them expressed substantially more pre-mRNA
message suggests that CD68 expression in the nonpermissive
cells is controlled, to some degree, by failings in the
processing of the mRNA.
Analysis of the elongation form of Pol II
Since the CTD of Pol II, and in particular its phosphorylation
state, mediates coupling between transcription and pre-mRNA
processing we decided to analyze the phosphorylation states of
Pol II transcribing the CD68 gene in the different cells. First, to
determine whether the differences in the CD68 mRNA levels
synthesized in the different cell lines were dependent on the
processing form of Pol II we tested the effect of the kinase
inhibitor 8-(methylthio)-4,5-dihydrothieno[3′,4′:5,6]benzoi-
soxazole-6-carboxamide (KM05283), which specifically inhi-
bits serine 2 phosphorylation of Pol II CTD [30]. Western blot
analysis of total cell lysates from THP-1 cells untreated (−) or
treated (+) with KM05283 (100 μM) for 2.5 h were probed with
antibodies specific for Pol II phosphorylated on serine 2 (α-H5)
or serine 5 (α-H14). The inhibitor caused a loss of only the
serine-2-specific form of Pol II as the signal detected with the α-
H14 antibody remained unchanged after drug treatment
(Fig. 2A).
Second, to determine the effect of inhibiting the serine-2-
phosphorylated Pol II on CD68 mRNA levels THP-1, Raji,
and Jurkat cells were treated with KM05283 (100 μM) for 1,
2.5, and 4 h. After 1-h drug treatment the CD68 mRNA was
reduced by on average 80% to almost undetectable levels at
4 h and all cell types were equally sensitive to KM05283
over the period of the time course (Fig. 2B). Real-time
analysis also confirmed that the CD68 mRNA was signifi-
cantly lower in the B and T lymphocytes (data not shown).
Taken together these results suggest thatCD68mRNA synthesis
in all three cell types requires the elongation-competent form of
Pol II.
Fig. 1. Monocytic cells express high levels of CD68 mRNA. (A) cDNA was prepared from total RNA from human monocytes THP-1 (lanes 1+2) and HL-60
(lanes 3+4), B lymphocytic cells lines Raji (lanes 5+6) and JY (lanes 7+8), and a T lymphocytic cell line Jurkat (lanes 9+10) by oligo(dT) synthesis. CD68
cDNA was PCR amplified using primers spanning introns 1, 2, 3, 4, and 5; see Materials and methods for primer sequences. Amplification of GAPDH was used
as a loading control. Lanes 1, 3, 5, 7, and 9 and lanes 2, 4, 6, 8, and 10 correspond to reverse transcriptase (RT) reactions minus and plus the RT enzyme,
respectively. (B) Real-time PCR results measuring relative levels of CD68 mRNA in the different cell types. Primers were designed to cross exon boundaries, see
Materials and methods for primer sequences. Black bars correspond to mRNA levels over exon1/exon2 and gray bars to exon4/exon5. After subtraction of
background levels from minus RT reactions, results were normalized to GAPDH mRNA levels detected in each cell type. CD68 mRNA levels obtained from
THP-1 cells were set at 100%. All other levels were normalized to this value. Error bars (S.D.) are representative of two independent experiments. (C) Real-time
PCR results measuring relative levels of CD68 pre-mRNA in the different cell types. CD68 pre-mRNA was PCR amplified using primers targeted to intron 1; see
Materials and methods for primer sequences. After subtraction of background levels from minus RT reactions, results were normalized to GAPDH mRNA levels.
CD68 pre-mRNA levels obtained from JY cells were set at 100%. All other levels were normalized to this value. Error bars denotes standard deviations (S.D.)
from two independent experiments. (D) Real-time PCR results measuring the relative levels of CD68 pre-mRNA to mRNA in the different cell types.
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and terminator regions of the CD68 gene in the nonpermissive
cell lines
To assess whether the differences in CD68 expression in the
permissive and nonpermissive cell lines were due to changes in
the distribution of the alternate form of Pol II (serine-5-
phosphorylated CTD form) we performed a chromatin
immunoprecipitation assay (ChIP). Using antibodies directed
to Pol II we could measure the distribution of the phosphory-
lated forms of Pol II across the CD68 gene. Briefly, cells were
cross-linked with formaldehyde, as described under Materials
and methods, and protein-DNA complexes were immunopre-cipitated with the validated antibodies, α-H5 and α-H14.
Precipitated DNA was used as template for real-time PCR
amplification with four genomic primer pairs specific for the
promoter, coding regions and 3′ untranslated region (UTR) of
the CD68 gene. As a comparative control, we used the γ-actin
gene, which is actively expressed in both these cell types. Fig.
3A shows a schematic representation of both genes and the
locations of the genomic primers used. Buffer alone and no-
antibody control reactions were also prepared to control for
PCR specificity. The distribution of the phosphorylated forms
of Pol II across the CD68 gene was assayed in the permissive
THP-1 monocytic cells and the nonpermissive Jurkat T
lymphocytic cells. In both cell lines tested the serine-2-
Fig. 2. Expression of CD68 in the different cell types requires the elongation form of Pol II. (A) Western blot of THP-1 cells before and after treatment with 100 μM
KM05283 for 4 h probed with anti-serine-2-phosphorylated Pol II antibody (α-H5) and anti-serine-5-phosphorylated Pol II antibody (α-H14). (B) Real-time PCR
results measuring the relative abundance of mRNA in the different cell types after treatment with KM05283. For each cell type the levels of mRNA obtained from the
untreated sample were normalized to 1. mRNA levels in the presence of the drug were calculated accordingly relative to this value. Error bars (S.D.) are representative
of two independent experiments.
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CD68 gene (Fig. 3B). This is consistent with our previous data
that suggest the requirement for Pol II phosphorylation on
serine 2 of the CTD for CD68 expression in the different cell
types (Figs. 2B and C). A similar pattern of serine-2-
phosphorylated Pol II was associated with the γ-actin gene in
both cell types. Interestingly, the serine-2-phosphorylated levels
were significantly reduced in the nonpermissive cells for the
CD68 gene, which was not apparent in the γ-actin gene. It is
also worth noting that, in contrast to yeast studies, the increased
levels of the serine-2-phosphorylated form of Pol II at the
promoter regions is consistent with data from studies on other
mammalian genes [31].
The ChIP profile obtained with the α-H14 antibody that
specifically immunoprecipitates the serine-5-phosphorylated
form of Pol II in the permissive cells was quite different from
that in the nonpermissive cells for the CD68 gene (Fig. 3C). In
the THP-1 monocytic cells this phosphorylated serine 5 form
was highest over the CD68 promoter and dropped to lower
levels at the terminator region. Real-time PCR analysis revealed
that at least 60% of this phosphorylated form of Pol II is lost by
the time the polymerase reaches the 3′ UTR region. A different
ChIP profile was obtained across the CD68 gene in the
nonpermissive lymphocytic cell line Jurkat. We consistently
found maximal levels of serine-5-phosphorylated Pol II over
both the promoter and the terminator regions of the gene. The
phosphorylation profile obtained over the γ-actin gene in both
cell types is very similar to that observed for CD68 in the
permissive THP-1 cells. Therefore, actively expressing genes
appear to share a common serine-5-phosphorylated Pol II profile
that appears to be lost in cells that weakly express the gene.Changes in chromatin architecture of the CD68 gene in the
nonpermissive cells
Recent data have shown that high levels of serine-5-
phosphorylated Pol II over the promoter and terminator regions
of a gene may suggest that these regions are in close spatial
proximity [25]. To determine whether the CD68 gene exists in a
gene looped structure in the nonpermissive cells we performed
the 3C technique [29]. Briefly, whole myeloid cells were cross-
linked using formaldehyde, digested with a restriction enzyme,
and ligated at very low DNA concentrations that favor
intramolecular interactions. After ligation, the crosslinks were
reversed and the ligation products were detected by PCR. The
resulting PCR amplicons were cloned and DNA sequence
analysis confirmed that the PCR products were derived from the
ligation of expected fragments. Using this technique we
analyzed the structure of the CD68 gene in the permissive
cell line THP-1 and the two nonpermissive cell lines Raji and
Jurkat using the restriction enzyme Bpm I to digest the
chromatin preparations. Fig. 4A shows a schematic representa-
tion of the CD68 gene and the locations of the genomic primers
and the Bpm I restriction sites. Fig. 4B shows the results of the
3C assay. Intramolecular ligation between two adjacent
fragments of the γ-actin gene was used as loading control
between the different cell lines. To ensure that the PCR was in
the linear range, reactions were performed for 29 and 33 cycles
(Fig. S1). As a control for restriction and ligation, genomic
DNA enriched with a PCR amplicon of the CD68 gene from
−249 to +3200 was restricted with Bpm I and ligated as
described under Materials and methods. PCRs using the primer
pairs outlined in Fig. 4B yielded PCR products of the expected
Fig. 3. Serine-5-phosphorylated Pol II localizes to the promoter and terminator regions of the CD68 gene in the nonpermissive cell lines. (A) Schematic representations
of the CD68 gene and the γ-actin gene. Black boxes represent exons and thin lines represent intron sequences. The shaded box is the 3′ UTR region of the CD68 gene.
PCR products are depicted as bars under the genes. (B) Real-time PCR results for quantitation of the serine-2-phosphorylated form of Pol II associated with the CD68
and the γ-actin genes in the permissive THP-1 monocytic cells (top graphs) and the nonpermissive, Jurkat T lymphocytic cells (bottom graphs,). Gray bars represent
no-antibody controls. Error bars denotes standard deviations (S.D.) from two independent experiments. (C) Real-time PCR results for quantitation of the serine-5-
phosphorylated form of Pol II associated with the CD68 and the γ-actin genes in the permissive THP-1 monocytic cells (top graphs) and the nonpermissive, Jurkat T
lymphocytic cells (bottom graphs). Gray bars represent no-antibody controls. Error bars denotes standard deviations (S.D.) from three independent experiments. All
immunoprecipitations are expressed relative to input.
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ends (Fig. 4C).
Primers 1+2 and 1+3 generated a PCR product, indicative
of intramolecular ligation, in all cell types. However, the
intensity of the band was much greater in the B and T cell lines,
indicating that the promoter region is in close proximity with the
5′ open reading frame region of the CD68 gene in these cells.
The absence of PCR products with primers 1+4 and 1+5,
which target the same fragment, in all cell types indicated that
these nonadjacent fragments did not exist in close proximity. By
contrast, 1+6 and the oppositely orientated 1+7 primers both
produced products in all cell types. Again the intensity of the
band was much greater in the nonpermissive cells than in the
monocytic cells. These data suggest that the CD68 gene exists
in a looped conformation in the nonpermissive cell lines,
consistent with our ChIP experiment (Fig. 3C). To determine
whether this looped structure extends beyond the 3′ UTR we
used an additional primer to the 3′ intervening sequence.
Primers 1+8 gave no PCR product in the nonpermissive cells,
indicating that this looped structure did not extend beyond the
terminator region in these cells. However, we did obtain an
unexpected result with the monocytic cells. A PCR product was
obtained which indicates that the promoter region of the CD68gene is in close proximity to the 3′ intervening sequences in
cells that actively transcribe this gene. The 3C experiment
suggests that the CD68 gene exists in a gene looped structure in
all cell types analyzed and that changes in this structure appear
to be associated with the transcriptional status of the gene in the
different cells.
Discussion
In this study we have analyzed the expression of the human
CD68 gene in different hematopoietic cell types. We have
shown that B and T lymphocytes have significantly higher
levels of the CD68 pre-mRNA than the myeloid cell lines
tested. Using ChIP assays we have demonstrated different
distributions of the phosphorylated forms of Pol II, in particular
the serine 5 form, across the human CD68 gene in the
nonpermissive and permissive cell lines and 3C analysis has
shown that the chromatin structure of the CD68 gene is further
altered in the cells that poorly express the gene. Taken together,
these three lines of experimental evidence lead us to propose
that previously unrecognized short-range (2.5-kb) changes in
chromatin architecture contribute to myeloid-specific expres-
sion of the human CD68 gene.
Fig. 4. Changes in CD68 architecture in the different cell types. (A) Schematic representation of the CD68 gene. Black boxes represent exons, thin lines represent
intron sequences, and the shaded box is the 3′ UTR region. The Bpm I sites are illustrated by vertical lines above the gene and arrows represent the primers used for 3C
analysis. (B) 3C analysis of the CD68 gene in the permissive THP-1 cells and the nonpermissive Raji cells and Jurkat cells. The primer pairs used in the 3C assay are
indicated. Primers to two adjacent Bpm I fragments of the γ-actin gene were used as a loading control. All PCR products were cloned and sequenced to confirm
ligation of compatible ends. (C) DNA intermolecular ligation controls. As a control to correct for ligation and amplification efficiencies a 3.5-kb region from a CD68
cosmid clone was PCR amplified in fragments, mixed with genomic DNA, digested with Bpm I, religated, and subjected to PCR amplification with the corresponding
primers.
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in myeloid cells are as expected with high levels of both serine-
2- and 5-phosphorylated Pol II associated with the beginning of
the gene and significant levels of serine-2-phosphorylated Pol II
across the gene. Serine-5-phosphorylated Pol II is required for
transcription initiation and the recruitment of capping enzymes
on the newly transcribed pre-mRNA [32,33]. Uncapped pre-
mRNA is unstable and rapidly turns over. The alternate
phosphorylated form of Pol II, i.e., the serine 2 form, is
necessary for transcription elongation and cotranscriptional
processing [34–36]. Interestingly, the recruitment of both of
these forms of Pol II are significantly reduced on the CD68
gene in the nonpermissive cells compared to the permissive
cells and the control gene in both cell types (Figs. 3B and 3C).
Changes in the levels of such forms of Pol II would undoubtedlyhave dramatic affects on the levels of both transcription and
processing of the mature CD68 message (Fig. 1A). Further-
more, interferon regulatory factor-4 has been shown to
specifically associate with the CD68 promoter in B lympho-
cytes [7]. It is plausible that this factor or an as yet unknown
factor(s) may directly or indirectly affect the regulation of Pol II
phosphorylation in these cells. It is also plausible that the
differences in the genomic structure of the CD68 gene in the
different cell types influence the association or disassociation of
essential factors that in combination are sufficient for the
regulation of efficient transcription, elongation, and mRNA
processing.
Chromatin loops have been proposed as a mechanism for
bringing together DNA and proteins within a defined subregion
of the nucleus to facilitate activation or silencing of gene
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cis and in trans and can involve up to hundreds of kilobases of
DNA [39,40]. However, very little is known about the structure
of individual genes and whether short-range interactions
between local DNA regulatory elements play a part in their
regulation. In yeast, recent data have demonstrated that gene
loops can indeed form between promoter and terminator
regions, over a distance of approximately 7 kb, of genes poised
for transcription, and that phosphorylation of Pol II on serine 5
in the CTD is associated with this structure [25]. The human
CD68 gene spans a region of just 2.5 kb. Our data show for
the first time that gene loops can form over this short distance in
mammalian cells. The CD68 gene, in the nonpermissive cells,
adopts a gene loop structure involving the promoter and the
terminator regions similar to that described in yeast. Pol II
phosphorylated on serine 5 is associated with this structure as
ChIP experiments show that the levels of this form were high
over both ends of the gene. Therefore genes poised for
transcription appear to share a common architecture that is
typified by changes in the phosphorylation state of RNA
polymerase II across the gene. In this study, however, the gene
loop structure described above was lost in cells that actively
express the CD68 gene. An alteration of gene architecture that
shifted the association of the promoter with the terminator
region further downstream into the 3′ intervening region was
apparent. This change in structure was also associated with
changes in the phosphorylation states of Pol II. The levels of
serine-5-phosphorylated Pol II were at a maximum only over
the promoter region, which is a common feature of actively
transcribing genes [31].
The existence of multiple loop structures to regulate
mammalian gene expression has been seen in studies investi-
gating the regulation of T helper type 2 (TH2) cytokines, Il4, Il5,
and Il13 [41,42]. A cell-lineage-independent loop structure was
formed between all three promoters. A further change in
chromatin structure was characterized in CD4+T cells and
natural killer cells involving interactions with the TH2 locus
control region. In this study they went on to propose that
expression of the TH2-specific cytokine-encoding genes, from
this poised chromatin configuration, is directed by TH2-specific
transcription factor and that lack of expression may be due to
insufficient phosphorylation of Pol II. We propose that
regulated expression of CD68 in myeloid cells may adopt a
similar mechanism. The structure characterized in B cells and T
cells may arise from a chromatin conformation that is necessary
during the early stages of myelogenesis to silence the CD68
gene. As the cells differentiate the regulation of specific cell
lineage transcription factors that specifically associate to the
promoter or 3′ intervening region of the CD68 gene may alter
the gene architecture in favor of maximal expression in the
permissive cells. We have previously shown that the CD68 gene
is regulated in a cell-type-specific manner by interactions
between the hematopoietic-specific Ets transcription factor
PU.1 and the lymphoid-restricted interferon regulatory factor
member IRF-4 [7]. IRF-4 associates with the promoter in vivo
in nonpermissive cells only and forms heterocomplexes with
PU.I to specifically downregulate the gene in these cells. Wecan postulate that sequences 3′ of the CD68 gene may form a
loop with the CD68 promoter region in the permissive cells to
either block the association of IRF-4 to this region or recruit as
yet uncharacterized activator or chromatin remodeling factors.
The CD68 gene is one of nine genes in a 140-kb region of
the human chromosome 17p13 [43]. All of the genes clustered
around CD68 have very different expression profiles, being
expressed in different tissues with very different developmental
specificities. Therefore, it is quite plausible that short-range
interactions between regions spanning the CD68 gene play an
important role in enhancing its cell-type-specific expression.
Further studies are required to analyze the role of consensus
sequences within this 3′ region of the CD68 gene for
macrophage-specific gene expression and to characterize the
protein complexes associated with this region and their ability to
interact with complexes at the promoter.
In this study we have shown that alterations in gene
architecture are associated with changes in the phosphorylation
state of Pol II across the gene, which in turn has downstream
effects onmRNA synthesis and processing.We postulate that the
expression of the macrophage-specific gene CD68 is regulated
at multiple levels, which are inextricably interconnected.
Materials and methods
Mammalian cell culture
All human cell lines including the monocytic leukemia cell line THP-1, the
promyelocytic leukemia cell line HL6O, the B lymphomas Raji and JY, and the
T lymphocytic cell line Jurkat were maintained in RPMI 1640 medium
(Invitrogen) supplemented with 10% heat-inactivated fetal calf serum (Invitro-
gen), 100 units ml−1 penicillin, 100 μg ml−1 streptomycin, and 2 mM glutamine;
100 μM (final concentration) of KM05283 (Maybridge) was added to 1×106
cells in a 60-mm plate for 1, 2.5, or 4 h before harvesting. The untreated samples
were harvested after 4 h.
RT-PCR and real-time PCR
RNA was extracted with Trizol reagent (Invitrogen). Reverse transcription
reactions were performed with M-MLV-RT enzyme (Promega) and oligo
(dT)(12-20) (Roche) or random hexamers (Stratagene). Total RNA was treated
with DNase 1 (Promega) and the reverse transcriptase enzyme was omitted in
some cDNA preparations to control for genomic DNA contamination. Results
were quantified using a QuantiTect SYBER Green kit (Qiagen) on the Corbett
Rotor-gene 3000 system. CD68 mRNA/pre-mRNA primers were as follows:
Intron 1 5′-GGCTGGCTGTGCTTTTCTCGG-3′ and 5′-GCTCTTGGTAGTCC-
TGTGG-3′, Intron 2 5′-GTCATGTACACAACCCAGGGTG-3′ and 5′-
GGTGTCCATAGGGGAATGAGAG-3′, Intron 3 5′-CCATCCCCACCT-
GCTTCT-3′ and 5′-GTGCTGCGTGGGGGAAGGAC-3′, Intron 3+4 5′-
CCATCCCCACCTGCTTCT-3′ and 5′-CATTCTGAGCCGAGAATGTCC-3′,
Intron 5 5′-CCTGAGGCTCCAGGCTGCTC-3′ and 5′-CTCCGGATGATGCA-
GAAAGC-3′. CD68 mRNA primers were exon1/2 5′-GCTACTGGCAGCCC-
CAGGG-3′ and 5′-GCTCTTGGTAGTCCTGTGG-3′, exon4/5 5′-
CTTTGGGCAAGGTTTCTCCTGCC-3′ and 5′-CTCCGGATGATGCA-
GAAAGC-3′. CD68 pre-mRNA primers were 5′-GCACCCATGTGAA-
CACTGTTG-3′ and 5′-GCTCTTGGTAGTCCTGTGG-3′. GADPH control
primers were 5′-GATGCCCCCATGTTTGTGAT-3′ and 5′-GGTCAT-
GAGCCCTTCCACAAT-3′. CD68 ChIP primers were 1 5′-GGCTGGCTGT-
GCTTTTCTCGG-3′ and 5′-GCTCTTGGTAGTCCTGTGG-3′, 2 5′-
CCATCCCCACCTGCTTCT-3′ and 5′-GTGCTGCGTGGGGGAAGGAC-3′, 3
5′-GGCAAAGTAAGACCTACCTACTC-3′ and 5′-CTGGCAGAGTCTTGTA-
GAGG-3′, and 4 5′-GTACCCTTATTTCCTCGACACG-3′ and 5′-
CCTCCCAAGTAGCTGGGATTAC-3′. γ-actin ChIP primers were described
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0.1μMfor real-time analysis.We diluted input DNA forChIP analysis to 1:30 and
1:2 for total and ChIP samples, respectively, to ensure that results were within the
linear range of amplification. RT-PCR conditions were standardized to 32 cycles
to detect mRNA and pre-mRNA and 29 cycles to detect mRNA only. Real-time
PCRs were standardized to 40 cycles. All PCRs included a 95 °C hotstart for
15 min, followed by cycling at 95 °C for 30 s, 57 °C for 30 s, and 72 °C for 30 s
followed by 72 °C for 8 min. For adjustment of amplification efficiency of each
primer pair in the ChIP experiments, PCR signal intensities from chromatin-
immunoprecipitatedDNAwere normalized to a standard curve of inputDNA. The
association of Pol II across the CD68 gene was expressed relative to input.
ChIP analysis
Chromatin immunoprecipitations were performed as previously described
with the following modifications [7]. A phosphatase inhibitor cocktail (Sigma)
was included in all buffers at a 1:1000 dilution. We used 1 μg of antibodies
specific to the serine-5-phosphorylated CTD form of Pol II (α-H14; Covance)
and the serine-2-phosphorylated form (α-H5; Covance) per immunoprecipita-
tion. In addition, 1 μg of anti-mouse immunoglobulin M was added to the
primary immunoprecipitates the following day for 1 h at 4 °C. We purified
templates for real-time PCR using a QIAquick PCR purification Kit (Qiagen)
and eluted the DNA in TE (pH 7.5) (50 μl). Primers sequences and PCR
conditions are outlined above.
3C analysis
We performed the 3C analysis as follows: 1×107 cells were cross-linked
with 1% formaldehyde for 10 min at room temperature. Cross-linking was
stopped by the addition of 0.125 M glycine for 5 min at room temperature. Cells
were washed twice in ice-cold phosphate-buffered saline and nuclei were
harvested in ice-cold lysis buffer (10 mM Tris, 10 mM NaCl, 0.2% Nonidet P-
40, 1 μg ml−1 pepstatin, 1 μg ml−1 aprotinin, 1 μg ml−1 trypsin inhibitor, and
1 μM phenylmethylsulfonyl fluoride (pH 8.0)) for 20 min at 4 °C. Nuclei were
resuspended in the appropriate restriction buffer plus 0.3% SDS and incubated
for 1 h at 37 °C while shaking. Triton X-100 was added to a final concentration
of 1.8%, to sequester the SDS, and incubated for 1 further h at 37 °C. The nuclei
were washed twice in the appropriate restriction buffer. The nuclei were counted
on a hemocytometer and 1×106 nuclei were digested with the restriction enzyme
Bpm I overnight at 37 °C. The reaction was stopped by the addition of SDS to
1.6% and incubation at 65 °C for 15 min. One tenth of the sample was diluted
into 800 μl of ligase buffer (66 mM Tris, 50 mM MgCl2, 50 mM dithiothrectol,
10 mM ATP (pH 7.5)) plus Triton X-100 at a final concentration of 1% and
incubated at 37 °C for 1 h. The DNAwas ligated with 30 weiss units of T4 ligase
(Roche) for 2 h at room temperature. RNAwas removed by the addition of 10 μg
of RNase (Roche) and cross-links were reversed by incubation at 65 °C for 4–
5 h and precipitated overnight at 4 °C. Pellets were resuspended into proteinase
K buffer (10 mM Tris, 5 mM EDTA, 0.25% SDS (pH 7.5)) plus 0.2 mg ml−1
proteinase K (Roche) and incubated at 45 °C min for 2 h. DNA was purified
using a QIAquick PCR purification Kit (Qiagen) and eluted in TE (pH 7.5)
(50 μl). To prepare for a control template for ligation and amplification
efficiencies we enriched for ligation products by PCR amplifying the entire
CD68 gene (up to 3.5 kb) from a CD68-containing cosmid clone. This fragment
was gel purified, restricted with Bpm I in the presence of 300 ng of genomic
DNA, and ligated without dilution using the conditions outlined above. The
DNA was purified using a QIAquick PCR purification Kit (Qiagen) and
eluted in TE (pH 7.5) (50 μl).
PCR analysis of 3C products
The 3C PCR primers used were as follows: γ-actin forward primer 5′-
GCTGTTCCAGGCTCTGTTCC-3′ and reverse 5-ATGCTCACACGCCA-
CAACATGC-3′. CD68 primers 1 5′-GCACCCATGTGACACTGTTG-3′, 2
5′-GCTCTTGGTAGTCCTGTGG-3′, 3 5′-GTGCTGCGTGGGGGAAGGAC-
3′, 4 5′-CTGGAGGAGTGAGGAAGGG-3′, 5 5′-GCATTCTGAGCCGA-
GAATGTCC-3′, 6 5′-CTGGCAGAGTCTTGTAGAGG-3′, 7 5′-GTACCCT-
TATTTCCTCGACACG-3′, and 8 5′-GAATGGCTCTACCGGCTTGC-3′.PCR products were gel purified, cloned into the TA vector, pCR 2.1-TOPO
(Invitrogen), and sequenced to confirm ligation of expected fragments with
compatible ends. PCR conditions were standardized to 95 °C for 15 min
followed by 33 cycles of 95 °C for 30 s, 57 °C for 30 s, and 72 °C for 30 s
followed by 8 min at 72 °C. The linear range of amplification was determined
by varying cycle number.
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